Corvus Pharmaceuticals, Inc. Liquidation Value
CRVS
Other
Cash & Equivalents
$4.58M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $4.58M
Total Obligations: -$10.32M
$-5.74M
Per share: $-0.08
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $4.58M
AR: $37,000
Total Obligations: -$10.32M
$-5.70M
Per share: $-0.08
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $4.58M
AR: $37,000
Inventory: $0
Total Obligations: -$10.32M
$-5.70M
Per share: $-0.08
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-5.74M | $-0.08 |
| Liquid Liquidation Value | $-5.70M | $-0.08 |
| Operating Liquidation Value | $-5.70M | $-0.08 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $4.58M |
| Accounts Receivable | $37,000 |
| Inventory | N/A |
| Current Liabilities | $9.38M |
| Long-term Debt | N/A |
| Op. Lease Liability | $937,000 |
| Finance Lease | N/A |
| Shares Outstanding | 74.7M |
Explore all 136 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $4.58M | $37,000 | N/A | $2.49M | $9.38M | N/A | $937,000 | N/A |
| 2025-09-30 | $2.87M | $32,000 | N/A | $1.97M | $8.07M | N/A | $1.01M | N/A |
| 2025-06-30 | $14.69M | $86,000 | N/A | $3.14M | $8.51M | N/A | $1.08M | N/A |
| 2025-03-31 | $5.00M | $79,000 | N/A | $1.31M | $9.28M | N/A | $1.15M | N/A |
| 2024-12-31 | $8.74M | $75,000 | N/A | $2.58M | $35.40M | N/A | $1.12M | N/A |
| 2024-09-30 | $4.68M | $70,000 | N/A | $1.87M | $46.41M | N/A | $354,000 | N/A |
| 2024-06-30 | $14.84M | $35,000 | N/A | $1.21M | $13.34M | N/A | $700,000 | N/A |
| 2024-03-31 | $7.46M | $26,000 | N/A | $1.61M | $6.72M | N/A | $1.04M | N/A |
▼ Community Notes